Amrutanjan Health Care Limited (BOM:590006)
492.55
-2.20 (-0.44%)
At close: Aug 17, 2026
Amrutanjan Health Care Revenue
Amrutanjan Health Care had revenue of 1.03B INR in the quarter ending June 30, 2026, with 9.49% growth. This brings the company's revenue in the last twelve months to 5.11B, up 10.68% year-over-year. In the fiscal year ending March 31, 2026, Amrutanjan Health Care had annual revenue of 5.03B with 11.19% growth.
Revenue (ttm)
5.11B
Revenue Growth
+10.68%
P/S Ratio
2.80
Revenue / Employee
6.94M
Employees
737
Market Cap
14.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.03B | 505.89M | 11.19% |
| Mar 31, 2025 | 4.52B | 305.93M | 7.26% |
| Mar 31, 2024 | 4.21B | 416.12M | 10.96% |
| Mar 31, 2023 | 3.80B | -261.89M | -6.45% |
| Mar 31, 2022 | 4.06B | 729.35M | 21.90% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| TTK Healthcare | 8.88B |
| Venus Remedies | 8.11B |
| Fredun Pharmaceuticals | 7.44B |
| Sudarshan Pharma Industries | 7.32B |
| Lincoln Pharmaceuticals | 7.03B |
| Kopran | 7.00B |
| Wanbury | 6.53B |
| Fermenta Biotech | 5.11B |
Amrutanjan Health Care News
- 2 months ago - Amrutanjan Health Care secures approval for director appointments via postal ballot - Business Upturn
- 2 months ago - Amrutanjan Health Care appoints Ramaswami Krishnan to key committee roles - Business Upturn
- 10 months ago - Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm in Classic Glass Packaging - Business Upturn